Health
Chronic & Non Communicable Diseases
Health Technologies
Respiratory Diseases
Wearables, Devices & IoT
Ph.D
France
2010.10.31
Determination of optimal PEP level for speech under patient control in tracheostomized ventilator-dependant subjects
Tracheostomized patients require respiratory support for survival. Marine Garguilo is testing a new device, which, controlled by the patients, allows them to speak more fluidly while avoiding the risk of excessive pressure in the airways.
This researcher is also supported by the Garches Foundation.
This researcher is also supported by the Garches Foundation.
Drop the pressure
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Marine
GARGUILO
Institution
Fondation Garches
Country
France
Nationality
French
Related articles
Health
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
.thumbnail.jpg)